- Publications
- Influence
Share This Author
A variant upstream of IFNL3 (IL28B) creating a new interferon gene IFNL4 is associated with impaired clearance of hepatitis C virus
- L. Prokunina-Olsson, B. Muchmore, T. O'Brien
- Biology, MedicineNature Genetics
- 1 February 2013
TLDR
ACG Clinical Guideline: The Diagnosis and Management of Idiosyncratic Drug-Induced Liver Injury
- N. Chalasani, P. Hayashi, H. Bonkovsky, V. Navarro, William M. Lee, R. Fontana
- MedicineThe American Journal of Gastroenterology
- 1 July 2014
TLDR
Recommendations for the Diagnosis and Treatment of the Acute Porphyrias
- K. Anderson, J. Bloomer, R. Desnick
- MedicineAnnals of Internal Medicine
- 15 March 2005
TLDR
Causes, clinical features, and outcomes from a prospective study of drug-induced liver injury in the United States.
- N. Chalasani, R. Fontana, J. Rochon
- MedicineGastroenterology
- 1 December 2008
TLDR
Features and Outcomes of 899 Patients With Drug-Induced Liver Injury: The DILIN Prospective Study.
- N. Chalasani, H. Bonkovsky, J. Serrano
- MedicineGastroenterology
- 1 June 2015
TLDR
Peginterferon alfa-2a and ribavirin in patients with chronic hepatitis C who have failed prior treatment.
- M. Shiffman, A. D. Di Bisceglie, J. Everhart
- Medicine, BiologyGastroenterology
- 1 April 2004
BACKGROUND & AIMS
The most effective therapy currently available for treatment of chronic hepatitis C virus (HCV) is the combination of peginterferon and ribavirin. This study evaluated the…
Vascular Endothelium As a Contributor of Plasma Sphingosine 1-Phosphate
- K. Venkataraman, Yong-Moon Lee, T. Hla
- Biology, MedicineCirculation research
- 28 March 2008
Sphingosine 1-phosphate (S1P), an abundant lipid mediator in plasma, regulates vascular and immune cells by activating S1P receptors. In this report, we investigated the mechanisms by which high…
Predicting cirrhosis in patients with hepatitis C based on standard laboratory tests: Results of the HALT‐C cohort
- A. Lok, M. Ghany, C. Morishima
- MedicineHepatology
- 1 August 2005
TLDR
Incidence of hepatocellular carcinoma and associated risk factors in hepatitis C-related advanced liver disease.
- A. Lok, L. Seeff, Z. Goodman
- Medicine, BiologyGastroenterology
- 2009
TLDR
Outcome of sustained virological responders with histologically advanced chronic hepatitis C
TLDR
...
...